Page results
-
We are part of the MRC Centre for Neuromuscular Diseases and our team is actively involved in cutting-edge neuroscience research.
-
How to refer to infectious and tropical diseases.
-
The Neuroimmunology and CSF Laboratory at the Institute of Neurology, UCLH is a UKAS accredited medical laboratory No. 8045.
-
This page is for parents, carers and relatives whose child is having radiotherapy treatment to the eye (orbit). There are different conditions that may require radiotherapy to the eye such as retinoblastoma, orbital rhabdomyosarcomas, soft tissue sarcomas, lymphomas, or some other condition.
-
This page has been written for patients who are having radiotherapy to the breast or chest wall area.
-
CAR T-cell therapy is a cutting-edge treatment for certain blood cancers, offering new hope to patients whose illness hasn’t responded to standard treatments. University College London Hospitals (UCLH) is proud to be one of Europe’s leading centres for this advanced care.
-
Acute loss of sense of smell should be considered globally as a criterion for self-isolation, testing, and contact tracing for Covid-19 infection according to researchers at UCLH and UCL.
-
This page is for children and young people receiving Proton beam therapy. It explains what growth monitoring is and why it is important.
-
This page has been written for parents and carers whose child is having a single fraction (one treatment) total body irradiation (TBI) for a benign (non-cancerous) blood disorder such as sickle cell anaemia, aplastic anaemia, thalassaemia, or some other condition.
-
This page is intended for patients who suffer from laryngeal dystonia (formerly known as spasmodic dysphonia) who might benefit from this therapy.
File results
-
FOI/2024/0078 - Locally employed doctors at Trust
-
FOI/2024/0081 - Consultant doctors headcount
-
FOI/2024/0092 - Decision to cease Salvage RARP with nerve spare in 2023
-
FOI/2024/0095 - Hospital at home - Discharge and discharge to assess pathways
-
FOI/2024/0097 - Laboratory Information Management System (LIMS)/ pathology IT system
-
FOI/2024/0116 - Patient treatment due to noise levels of the London Underground
-
FOI/2024/0131 - Alpha-1 Proteinase-Inhibitor (AAT) purchased in 2023
-
FOI/2024/0140 - Operations cancelled due to low levels of staffing 2019-2023
-
FOI/2024/0147 - Permits to Work
-
FOI/2024/0151 - A&E decision-to-admit wait times 2019-2023